0 items

in your cart
$0.00

  • Search for Medications
  • Viewcart | Checkout
  • Manage Account
  •  
  • Click-to-Call  

Prescription Drug Search

Product Request Form

Ofatumumab is currently not available.

Our suppliers are constantly updating their product inventory and availability status. If you would like us to notify you when Ofatumumab becomes available, please fill out the form below.

Name:
Email:

*We value your privacy! We will never give, lease, sell or otherwise disclose your personal information. Period!

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about SaveRxCanada.to

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Ofatumumab:

  • Algeria
  • Anguilla
  • Argentina
  • Aruba
  • Azerbaijan
  • Belarus
  • Belize
  • China
  • Cook Islands
  • Costa Rica
  • Czech Republic
  • Denmark
  • Egypt
  • Greenland
  • Guam
  • Guatemala
  • Honduras
  • India
  • Indonesia
  • Iraq
  • Ireland
  • Kuwait
  • Luxembourg
  • Malta
  • Morocco
  • Nicaragua
  • Panama
  • Philippines
  • Poland
  • Saint Lucia
  • Singapore
  • Slovakia
  • Slovenia
  • Taiwan
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • United Kingdom, UK
  • United States, US
  • Uzbekistan
View All Countries

Latest news releases on Ofatumumab:

Ofatumumab - Genmab - Home

Ofatumumab is a human monoclonal antibody which targets an epitope in the CD20 molecule encompassing parts of the small and large extracellular loops.

European Medicines Agency - Find medicine - Arzerra

Product details for Arzerra; Name: Arzerra: Agency product number: EMEA/H/C/001131: Active substance: ofatumumab. International non-proprietary name (INN) or common name

Arzerra (ofatumumab) Drug Side Effects, Interactions, and ...

Drug information on Arzerra (ofatumumab), includes drug pictures, side effects, drug interactions, directions for use, symptoms of overdose, and what to avoid.

ARZERRA® (ofatumumab) | Patient Information

Discover ARZERRA® (ofatumumab), approved for 4 CLL treatment indications. Find dosing information & patient resources. See Important Safety Information & BOXED WARNING.

Product pipeline | GSK

A snapshot of our medicines and vaccines currently in development across three stages: phase I, phase II and phase III

Ibrutinib versus Ofatumumab in Previously Treated Chronic ...

Background In patients with chronic lymphoid leukemia (CLL) or small lymphocytic lymphoma (SLL), a short duration of response to therapy or adverse cytogenetic ...

Genmab - Wikipedia

Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund ...

Arzerra 100mg & 1000mg concentrate for solution for infusion

Arzerra 100mg & 1000mg concentrate for solution for infusion - Summary of Product Characteristics (SPC) by Novartis Pharmaceuticals UK Ltd

Ofatumumab for Rituximab-Resistant Nephrotic Syndrome — NEJM

Cases of the steroid-resistant nephrotic syndrome that are resistant to rituximab can be difficult to treat. In this report, ofatumumab, an anti-CD20 monoclonal ...

再発性/難治性CLL患者に対するibrutinib単剤 ...

新着一覧へ ニュース. 2014/6/5. 再発性/難治性CLL患者に対するibrutinib単剤投与はofatumumabに比べ有意な生存利益をもたらす ...

Customer Service
1-866-799-3435 | Contact Form
Copyright © 2017 SaveRxCanada.to All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK